IRIX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IRIX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
IRIDEX's total equity for the quarter that ended in Sep. 2024 was $2.62 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
The historical data trend for IRIDEX's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRIDEX Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Total Equity | Get a 7-Day Free Trial | 22.71 | 17.37 | 23.30 | 17.23 | 9.52 |
IRIDEX Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Total Equity | Get a 7-Day Free Trial | 12.06 | 9.52 | 6.49 | 4.25 | 2.62 |
Total Equity and Total Liabilities are the two components for Total Assets.
IRIDEX's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as
Total Equity | = | Total Assets(Q: Dec. 2023 ) | - | Total Liabilities(Q: Dec. 2023 ) |
= | 34.436 | - | 24.914 | |
= | 9.52 |
IRIDEX's Total Equity for the quarter that ended in Sep. 2024 is calculated as
Total Equity | = | Total Assets(Q: Sep. 2024 ) | - | Total Liabilities(Q: Sep. 2024 ) |
= | 30.154 | - | 27.531 | |
= | 2.62 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of IRIDEX's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Nandini Devi | director | 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043 |
Beverly A Huss | director | C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089 |
Robert Earle Grove | director | 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043 |
Topcon Corp | 10 percent owner | 75-1, HASUNUMA-CHO, ITABASHI-KU, TOKYO M0 174-8580 |
Topcon America Corp | 10 percent owner | 111 BAUER DRIVE, OAKLAND NJ 07426 |
Fuad Ahmad | officer: Interim CFO | 461 SOUTH MILPITAS BLVD., MILPITAS CA 95035 |
Doris Engibous | director | C/O NATUS MEDICAL INCORPORATED, 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Scott Shuda | director | 402 RAILROAD AVENUE, SUITE 201, DANVILLE CA 94526 |
Patrick Mercer | officer: COO | 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043 |
Maria Sainz | director | C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
Ruediger Naumann-etienne | director | |
Robert A Gunst | director | |
David Bruce | director, officer: President and CEO | 1178 GLEN ROAD, LAFAYETTE CA 94549 |
Ken Ludlum | director | |
Romeo R Dizon | other: Vice President and Controller | 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043 |
From GuruFocus
By Marketwired • 11-19-2024
By Marketwired • 11-12-2024
By Marketwired • 07-30-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 03-27-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By Marketwired • 05-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.